Somnigroup International (SGI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Somnigroup International (SGI) reported revenue of $2.12 billion, up 63.3% over the same period last year. EPS came in at $0.95, compared to $0.82 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $2.07 billion, representing a surprise of +2.71%. The company delivered an EPS surprise of +11.76%, with the consensus EPS estimate being $0.85.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Somnigroup International performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- North America: $736.1 million versus $732.72 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -27.5% change.Net Sales- International: $315.7 million compared to the $308.79 million average estimate based on three analysts. The reported number represents a change of +10.9% year over year.Net sales by Channel- Direct- Mattress Firm: $1.07 billion versus the three-analyst average estimate of $1.02 billion.Net Sales- International- Direct: $202.8 million versus the two-analyst average estimate of $196.52 million. The reported number represents a year-over-year change of +11.9%.Net Sales- International- Wholesale: $112.9 million versus $111.52 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +9.2% change.Net Sales- North America- Wholesale: $626.4 million versus the two-analyst average estimate of $605.19 million. The reported number represents a year-over-year change of -28.7%.Net Sales- North America- Direct: $109.7 million compared to the $107.39 million average estimate based on two analysts. The reported number represents a change of -19.9% year over year.Net Sales- Direct: $1.38 billion versus $1.32 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +334.7% change.Net Sales- Wholesale: $739.3 million versus the two-analyst average estimate of $716.71 million. The reported number represents a year-over-year change of -24.7%.Adjusted operating income (expense)- Mattress Firm: $100.9 million versus $103.4 million estimated by two analysts on average.View all Key Company Metrics for Somnigroup International here>>>Shares of Somnigroup International have returned -7% over the past month versus the Zacks S&P 500 composite's +1.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Somnigroup International Inc. (SGI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks